{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:30:17Z","timestamp":1772901017295,"version":"3.50.1"},"reference-count":43,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"4","license":[{"start":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T00:00:00Z","timestamp":1592092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Shoppers Drug Mart Professorship in Clinical Pharmacy","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Can Pharm J"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1177\/1715163520929373","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:43:16Z","timestamp":1592181796000},"page":"193-197","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["COVID-19 and the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers"],"prefix":"10.3138","volume":"153","author":[{"given":"Megan H.","family":"St. John","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences (St. John, Barry), Lower Mainland Pharmacy Services, Chilliwack, British Columbia"},{"name":"University of British Columbia, Vancouver, and Chilliwack General Hospital (Barry), Lower Mainland Pharmacy Services, Chilliwack, British Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0287-898X","authenticated-orcid":false,"given":"Arden R.","family":"Barry","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences (St. John, Barry), Lower Mainland Pharmacy Services, Chilliwack, British Columbia"},{"name":"University of British Columbia, Vancouver, and Chilliwack General Hospital (Barry), Lower Mainland Pharmacy Services, Chilliwack, British Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1696","published-online":{"date-parts":[[2020,6,14]]},"reference":[{"key":"bibr1-1715163520929373","unstructured":"World Health Organization. WHO Director-General\u2019s opening remarks at the media briefing on COVID-19. March 11, 2020. Available: https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19\u201411-march-2020 (accessed Apr. 20, 2020)."},{"key":"bibr2-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032"},{"key":"bibr3-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0118-9"},{"key":"bibr4-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2020.03.063"},{"key":"bibr5-1715163520929373","volume":"19","author":"Ortega JT","year":"2020","journal-title":"EXCLI J"},{"key":"bibr6-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr2005760"},{"key":"bibr7-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4812"},{"key":"bibr8-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21656"},{"key":"bibr9-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585"},{"key":"bibr10-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"bibr11-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1091"},{"key":"bibr12-1715163520929373","volume":"69","author":"CDC COVID-19 Response Team","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bibr13-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8"},{"key":"bibr14-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1042\/CS20130436"},{"key":"bibr15-1715163520929373","volume":"169","author":"Sim\u00f5es e","year":"2013","journal-title":"Br J Pharmacol"},{"key":"bibr16-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1038\/nm1267"},{"key":"bibr17-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.510461"},{"key":"bibr18-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000124667.34652.1a"},{"key":"bibr19-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1042\/CS20120162"},{"key":"bibr20-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198144"},{"key":"bibr21-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpu086"},{"key":"bibr22-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1038\/nature03712"},{"key":"bibr23-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2006.03.001"},{"key":"bibr24-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-007-6228-6"},{"key":"bibr25-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-0360-5"},{"key":"bibr26-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.0950"},{"key":"bibr27-1715163520929373","unstructured":"ClinicalTrials.gov. Losartan for patients with COVID-19 not requiring hospitalization (NCT04311177). Available: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04311177 (accessed Apr. 20, 2020)."},{"key":"bibr28-1715163520929373","unstructured":"ClinicalTrials.gov. Losartan for patients with COVID-19 requiring hospitalization (NCT04312009). Available: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04312009 (accessed Apr. 20, 2020)."},{"key":"bibr29-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.317134"},{"key":"bibr30-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1624"},{"key":"bibr31-1715163520929373","unstructured":"Bean DM, Kraljevic Z, Searle T, et al. Treatment with ACE-inhibitors is associated with less severe disease with SARS-Covid-19 infection in a multi-site UK acute hospital trust. Available: https:\/\/www.medrxiv.org\/content\/10.1101\/2020.04.07.20056788v1 (accessed Apr. 29, 2020)."},{"key":"bibr32-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2006923"},{"key":"bibr33-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008975"},{"key":"bibr34-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007621"},{"key":"bibr35-1715163520929373","unstructured":"Hypertension Canada. Hypertension Canada\u2019s statement on: hypertension, ACE-inhibitors and angiotensin receptor blockers and COVID-19. Available: https:\/\/hypertension.ca\/wp-content\/uploads\/2020\/03\/2020-30-15-Hypertension-Canada-Statement-on-COVID-19-ACEi-ARB.pdf (accessed Apr. 20, 2020)."},{"key":"bibr36-1715163520929373","unstructured":"Canadian Cardiovascular Society. COVID-19 and concerns regarding use of ACEi\/ARB\/ARNi medications for heart failure or hypertension. Available: https:\/\/www.ccs.ca\/images\/Images_2020\/CCS_CHFS_statement_regarding_COVID_EN.pdf (accessed Apr. 20, 2020)."},{"key":"bibr37-1715163520929373","unstructured":"Diabetes Canada. FAQ about COVID-19 and diabetes. Available: https:\/\/www.diabetes.ca\/resources\/tools-resources\/faq-about-covid-19-and-diabetes (accessed Apr. 20, 2020)."},{"key":"bibr38-1715163520929373","unstructured":"American College of Cardiology. HFSA\/ACC\/AHA statement addresses concerns re: using RAAS antagonists in COVID-19. Available: https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2020\/03\/17\/08\/59\/hfsa-acc-aha-statement-addresses-concerns-re-using-raas-antagonists-in-covid-19 (accessed Apr. 20, 2020)."},{"key":"bibr39-1715163520929373","unstructured":"International Society of Hypertension. A statement from the International Society of Hypertension on COVID-19. Available: https:\/\/ish-world.com\/news\/a\/A-statement-from-the-International-Society-of-Hypertension-on-COVID-19\/ (accessed Apr. 20, 2020)."},{"key":"bibr40-1715163520929373","unstructured":"European Society of Cardiology. Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers. Available: https:\/\/www.escardio.org\/Councils\/Council-on-Hypertension-(CHT)\/News\/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang (accessed Apr. 20, 2020)."},{"key":"bibr41-1715163520929373","unstructured":"The Renal Association. The Renal Association, UK position statement for patients: novel corona virus infection and the use of blood pressure medications. Available: https:\/\/renal.org\/covid-19\/ra-resources-renal-professionals\/renal-association-uk-position-statement-patients-novel-corona-virus-infection-use-blood-pressure-medications\/ (accessed Apr. 20, 2020)."},{"key":"bibr42-1715163520929373","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2017.10.045"},{"key":"bibr43-1715163520929373","unstructured":"NephJC. ACE2 and hypertension. Available: http:\/\/www.nephjc.com\/news\/covidace2 (accessed May 5, 2020)."}],"container-title":["Canadian Pharmacists Journal \/ Revue des Pharmaciens du Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1715163520929373","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1715163520929373","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1715163520929373","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:06:27Z","timestamp":1772834787000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1715163520929373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,14]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1177\/1715163520929373"],"URL":"https:\/\/doi.org\/10.1177\/1715163520929373","relation":{},"ISSN":["1715-1635","1913-701X"],"issn-type":[{"value":"1715-1635","type":"print"},{"value":"1913-701X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,14]]}}}